Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim R de Back

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Expert Review of Hematology|June 21, 2018
Autoimmune cytopenias in chronic lymphocytic leukemia: a concise review and treatment recommendationsTim R De Back, Arnon P Kater, Sanne H Tonino
Journal of the National Cancer Institute|June 2, 2021
Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-AnalysisSanne Ten Hoorn, Tim R de Back, Dirkje W Sommeijer, et al.
Plos One|September 23, 2015
Cardiovascular Health and Related Health Care Use of Moluccan-Dutch ImmigrantsTim R de Back, Adee J Bodewes, Lizzy M Brewster, et al.
Trends in Cancer|July 17, 2024
Transcriptomic subtyping of gastrointestinal malignanciesTim R de Back, Sander R van Hooff, Dirkje W Sommeijer, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2024
Incidence, clinical management and prognosis of patients with small intestinal adenocarcinomas from 1999 through 2019: A nationwide Dutch cohort studyTim R de Back, Jasmijn D G Linssen, Felice N van Erning, et al.
British Journal of Haematology|July 15, 2021
Fluid overload due to intravenous fluid therapy for vaso-occlusive crisis in sickle cell disease: incidence and risk factorsAafke E Gaartman, Ajab K Sayedi, Jorn J Gerritsma, et al.
International Journal of Cancer|February 5, 2025
Predisposing conditions in patients with small intestinal adenocarcinomas in the Netherlands: A 20-year nationwide cohort studyJasmijn D G Linssen, Pascale J M Schafrat, Tim R de Back, et al.
Acta Oncologica (Stockholm, Sweden)|April 28, 2026
Adenocarcinoma of the small intestine cohort: prospectively collecting real-world data to improve care and quality of life for patients with a rare cancerPascale J M Schafrat, Tim R De Back, Felice N Van Erning, et al.
British Journal of Cancer|July 13, 2021
Molecular subtype-specific efficacy of anti-EGFR therapy in colorectal cancer is dependent on the chemotherapy backboneSanne Ten Hoorn, Dirkje W Sommeijer, Faye Elliott, et al.
Molecular Oncology|March 17, 2022
Development of a miRNA-based classifier for detection of colorectal cancer molecular subtypesRonja S Adam, Dennis Poel, Leandro Ferreira Moreno, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Expert Review of Hematology|June 21, 2018
Autoimmune cytopenias in chronic lymphocytic leukemia: a concise review and treatment recommendationsTim R De Back, Arnon P Kater, Sanne H Tonino
Journal of the National Cancer Institute|June 2, 2021
Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-AnalysisSanne Ten Hoorn, Tim R de Back, Dirkje W Sommeijer, et al.
Plos One|September 23, 2015
Cardiovascular Health and Related Health Care Use of Moluccan-Dutch ImmigrantsTim R de Back, Adee J Bodewes, Lizzy M Brewster, et al.
Trends in Cancer|July 17, 2024
Transcriptomic subtyping of gastrointestinal malignanciesTim R de Back, Sander R van Hooff, Dirkje W Sommeijer, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2024
Incidence, clinical management and prognosis of patients with small intestinal adenocarcinomas from 1999 through 2019: A nationwide Dutch cohort studyTim R de Back, Jasmijn D G Linssen, Felice N van Erning, et al.
British Journal of Haematology|July 15, 2021
Fluid overload due to intravenous fluid therapy for vaso-occlusive crisis in sickle cell disease: incidence and risk factorsAafke E Gaartman, Ajab K Sayedi, Jorn J Gerritsma, et al.
International Journal of Cancer|February 5, 2025
Predisposing conditions in patients with small intestinal adenocarcinomas in the Netherlands: A 20-year nationwide cohort studyJasmijn D G Linssen, Pascale J M Schafrat, Tim R de Back, et al.
Acta Oncologica (Stockholm, Sweden)|April 28, 2026
Adenocarcinoma of the small intestine cohort: prospectively collecting real-world data to improve care and quality of life for patients with a rare cancerPascale J M Schafrat, Tim R De Back, Felice N Van Erning, et al.
British Journal of Cancer|July 13, 2021
Molecular subtype-specific efficacy of anti-EGFR therapy in colorectal cancer is dependent on the chemotherapy backboneSanne Ten Hoorn, Dirkje W Sommeijer, Faye Elliott, et al.
Molecular Oncology|March 17, 2022
Development of a miRNA-based classifier for detection of colorectal cancer molecular subtypesRonja S Adam, Dennis Poel, Leandro Ferreira Moreno, et al.
Pageof 2